Afuco™ Anti-Human PTK7 ADCC Recombinant Antibody, ADCC Enhanced

CAT#: AFC-692CL

Anti-PTK7 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies target protein tyrosine kinase 7 (PTK7). They can use in preventing, treating or ameliorating hyperproliferative disorders and any expansion, recurrence, relapse or metastasis.

Specifications

  • Host Species
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Cancer

Product Property

  • Purity
  • >95%, by SDS-PAGE, under reducing conditions
  • Storage
  • Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • PTK7; protein tyrosine kinase 7 (inactive); CCK4; CCK-4; inactive tyrosine-protein kinase 7; colon carcinoma kinase 4; PTK7 protein tyrosine kinase 7; tyrosine-protein kinase-like 7; pseudo tyrosine kinase receptor 7
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-692CL. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Great for Cancer Research
The Afuco™ Anti-PTK7 ADCC antibody has been a groundbreaking addition to my research on breast cancer. Its enhanced ADCC capability provides clear results, particularly when assessing PTK7 expression in malignant cells. This specificity and potency accelerate our understanding of PTK7's role in cancer progression.
Breast cancer biomarkers at key points during disease progression
Enhances Immune Assay Outcomes
The increased ADCC activity of this antibody has significantly boosted the outcomes of our immune assays. The enhanced recruitment of effector cells has provided new insights into PTK7-associated immune interactions, opening doors to further discoveries in immune-oncology.
Breast cancer biomarkers at key points during disease progression
Perfect for Collaborative Projects
We've used this antibody collaboratively across institutions, and its performance remains consistent irrespective of differing lab environments. This consistency facilitates comparative studies and multi-center research initiatives.

Q&As

  1. What is the main target of the Anti-PTK7 ADCC Enhanced Antibody?

    A: The main target of this antibody is protein tyrosine kinase 7 (PTK7). It is involved in numerous cellular processes and is particularly abundant in certain types of cancer cells. By targeting PTK7, this antibody aids in various research applications related to hyperproliferative disorders.

  2. Which types of cancer are related to PTK7 targets for this antibody?

    A: Research suggests PTK7 is involved in cancers such as colorectal carcinoma, gastric cancer, and breast cancer. This antibody could help in studying these cancers due to its precise targeting capabilities.

  3. Why is PTK7 considered an inactive kinase?

    A: PTK7 lacks key catalytic motifs typical of active kinases. Despite this, it plays essential roles as a cellular signaling co-factor, affecting cell proliferation and migration, which are processes of interest in cancer research.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "PTK7"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
VS-0425-FY170 Human Anti-PTK7 scFv-Fc Chimera (VS-0425-FY170) WB, ELISA, IHC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC670 Recombinant Anti-PTK7 Vesicular Antibody, EV Displayed (VS-0425-YC670) ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare